TARS vs PRAX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 22, 2026

TARS

32.7
AI Score
VS
PRAX Wins

PRAX

38.3
AI Score

Investment Advisor Scores

TARS

33score
Recommendation
SELL

PRAX

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric TARS PRAX Winner
Net Income -25.52M -214.36M TARS
Operating Income -26.03M -229.15M TARS
ROE -7.4% -62.4% TARS
ROA -4.2% -54.1% TARS
Total Assets 611.14M 396.39M TARS
Cash 204.59M 149.53M TARS
Current Ratio 3.20 5.18 PRAX
Free Cash Flow 26.68M -172.80M TARS

Relative Price Performance (Last 90 Days)

TARS 1M: +24.1% · 3M: +14.5% PRAX 1M: +16.6% · 3M: +7.2%

Current Technical Phase

TARS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 68

RSI (14): 67.5 · Price: $72.70

PRAX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.3% over 20 days), RSI 59

RSI (14): 59.4 · Price: $375.94

Fundamentals Snapshot

Metric TARS PRAX
Market Cap
Forward P/E 30.4 -38.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.7% 13.5%
Gross Margin 0.8% -39.0%
Operating Margin -0.1% 0.0%
EPS -1.07 -13.52
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PRAX is currently the stronger investment candidate, winning 1 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.